ReviewAnimals : an open access journal from MDPI2025
Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases.
Review in Animals : an open access journal from MDPI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural SARS-CoV-2 infection in farmed minksFrontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Aleutian mink disease virus (AMDV) poses a serious threat to the fur industry worldwide, and the lack of effective treatments or vaccines makes it difficult to combat the disease. There are highly virulent strains of AMDV that cause severe symptoms, but by selecting animals with low titres of anti-AMDV antibodies, it is possible to obtain mink with increased resistance to AMDV. Immunomodulation research offers a promising prospect in combating AMDV. The literature review covered the potential use of immunomodulators, including nanoparticles and macromolecules, which can positively influence the immune response. Previous attempts to treat AMDV have not been satisfactory, nor have attempts to develop a fully effective vaccine. The use of new technologies based on cell engineering and nanotechnologies in the prevention and treatment of diseases has become a fact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.